As of mid-August 2026, the CDC has recorded 2,566 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% linked to ongoing outbreaks across dozens of jurisdictions and the majority occurring in unvaccinated individuals. Sustained transmission in communities with MMR vaccination coverage well below the 95% herd-immunity threshold, combined with importations from international travelers, has driven this surge to levels unseen since 1991 and placed national elimination status (lost regionally in late 2025) under active review. Weekly CDC surveillance updates and any revised state-level case counts or model projections of fall transmission will provide the next key data points for assessing year-end totals.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,834,626 Vol.
$7,834,626 Vol.
31 dic 2026
↑4,5k
54%
↑3k
96%
↑3,5k
93%
↑4k
82%
↑5k
34%
↑7,5k
12%
↑10k
6%
↑12,5k
5%
$7,834,626 Vol.
$7,834,626 Vol.
31 dic 2026
↑4,5k
$20 Vol.
54%
↑3k
$90,831 Vol.
96%
↑3,5k
$13,530 Vol.
93%
↑4k
$222,556 Vol.
82%
↑5k
$230,696 Vol.
34%
↑7,5k
$185,156 Vol.
12%
↑10k
$6,516,152 Vol.
6%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has recorded 2,566 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% linked to ongoing outbreaks across dozens of jurisdictions and the majority occurring in unvaccinated individuals. Sustained transmission in communities with MMR vaccination coverage well below the 95% herd-immunity threshold, combined with importations from international travelers, has driven this surge to levels unseen since 1991 and placed national elimination status (lost regionally in late 2025) under active review. Weekly CDC surveillance updates and any revised state-level case counts or model projections of fall transmission will provide the next key data points for assessing year-end totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Feb 16, 2026, 11:51 AM ET
Volume
$7,834,626Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has recorded 2,566 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% linked to ongoing outbreaks across dozens of jurisdictions and the majority occurring in unvaccinated individuals. Sustained transmission in communities with MMR vaccination coverage well below the 95% herd-immunity threshold, combined with importations from international travelers, has driven this surge to levels unseen since 1991 and placed national elimination status (lost regionally in late 2025) under active review. Weekly CDC surveillance updates and any revised state-level case counts or model projections of fall transmission will provide the next key data points for assessing year-end totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,834,626Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC has recorded 2,566 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with 94% linked to ongoing outbreaks across dozens of jurisdictions and the majority occurring in unvaccinated individuals. Sustained transmission in communities with MMR vaccination coverage well below the 95% herd-immunity threshold, combined with importations from international travelers, has driven this surge to levels unseen since 1991 and placed national elimination status (lost regionally in late 2025) under active review. Weekly CDC surveillance updates and any revised state-level case counts or model projections of fall transmission will provide the next key data points for assessing year-end totals.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti